Tissue Regenix Group (LSE:TRX) Additional Paid-In Capital : £106.06 Mil(As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Additional Paid-In Capital?

Tissue Regenix Group's quarterly additional paid-in capital declined from Dec. 2022 (£110.16 Mil) to Jun. 2023 (£106.27 Mil) but then stayed the same from Jun. 2023 (£106.27 Mil) to Dec. 2023 (£106.06 Mil).

Tissue Regenix Group's annual additional paid-in capital increased from Dec. 2021 (£100.90 Mil) to Dec. 2022 (£110.16 Mil) but then declined from Dec. 2022 (£110.16 Mil) to Dec. 2023 (£106.06 Mil).

Tissue Regenix Group Additional Paid-In Capital Historical Data

The historical data trend for Tissue Regenix Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Additional Paid-In Capital Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

86.44

99.83

100.90

110.16

106.06

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															100.90	108.95	110.16	106.27	106.06

Tissue Regenix Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Tissue Regenix Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.